Skip to content

    TANDEM DIABETES CARE (TNDM) stock price & financials

    View TNDM earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+74.9% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $243.97M
    $282.65M
    $234.42M
    $240.68M
    $249.25M
    +2.2%
    $290.38M
    +2.7%
    $247.22M
    +5.5%
    $254.56M
    +5.8%
    Strengthening
    Operating Profit
    -$26.09M
    -$581.0K
    -$120.88M
    -$51.81M
    -$22.86M
    +12.4%
    $8.29M
    -$17.43M
    +85.6%
    -$13.79M
    +73.4%
    Strengthening
    Net Profit
    -$23.25M
    $755.0K
    -$130.56M
    -$52.40M
    -$21.16M
    +9.0%
    -$589.0K
    -178.0%
    -$20.39M
    +84.4%
    -$21.17M
    +59.6%
    Weakening
    EPS
    $-0.35
    $0.01
    $-1.97
    $-0.78
    $-0.31
    +11.4%
    $-0.01
    -200.0%
    $-0.30
    +84.8%
    $-0.31
    +60.3%
    Weakening
    Other Income
    Interest
    $1.86M
    $1.86M
    $1.86M
    $1.91M
    $2.06M
    +10.7%
    $2.08M
    +11.6%
    $2.20M
    +18.4%
    $2.45M
    +28.6%
    Strengthening
    Depreciation
    Profit before Tax
    -$22.61M
    $16.0K
    -$122.09M
    -$57.72M
    -$25.14M
    -11.2%
    $4.68M
    +29162.5%
    -$19.88M
    +83.7%
    -$20.66M
    +64.2%
    Strengthening
    MarginsOPM
    -10.7%
    -0.2%
    -51.6%
    -21.5%
    -9.2%
    +14.3%
    2.9%
    -7.0%
    +86.3%
    -5.4%
    +74.8%
    Strengthening
    Tax
    -2.8%
    -4618.8%
    -6.9%
    9.2%
    15.8%
    112.6%
    -2.6%
    +62.5%
    -2.5%
    -126.8%
    Weakening
    ReturnsROIC
    1.8%
    -0.1%
    10.1%
    4.0%
    1.6%
    -9.0%
    0.0%
    1.6%
    -84.4%
    1.6%
    -59.6%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$41.83M$51.17M$94.61M$71.18M$172.52M$58.87M$69.23M$90.63M$62.82M
    Short-Term Investments
    Total Current Assets$187.88M$276.14M$637.24M$811.52M$849.98M$747.99M$724.49M$618.14M$804.64M
    Net PP&E$17.15M$48.48M$69.80M$77.89M$179.18M$164.33M$163.46M$179.75M$184.69M
    Goodwill
    Intangibles$6.64M$4.63M$2.78M$925.0K$11.72M
    Total Assets$206.29M$326.11M$716.41M$905.14M$1.05B$952.66M$967.66M$881.11M$1.15B
    LiabilitiesTotal Current Liabilities$66.29M$99.40M$103.85M$131.86M$165.29M$195.26M$247.05M$242.72M$253.00M
    Short-Term Debt$0$40.67M
    Long-Term Debt$285.04M$308.27M$310.04M$602.58M
    Long-Term Leases$14.06M$15.91M$23.92M$123.52M$113.57M$106.42M$114.97M$116.41M
    Total Liabilities$75.02M$131.13M$350.11M$472.02M$612.84M$639.03M$704.56M$725.94M$1.02B
    EquityCommon Stock & APIC$57.0K$59.0K$62.0K$64.0K$65.0K$66.0K$66.0K$68.0K$70.0K
    Retained Earnings-$600.08M-$624.83M-$659.21M-$634.60M-$729.19M-$951.80M-$1.05B-$1.25B-$1.29B
    Total Equity$131.28M$194.98M$366.31M$433.11M$439.95M$313.63M$263.10M$155.17M$130.39M
    HighlightsNet Cash / (Debt)-$226.17M-$279.70M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$8.32M$41.91M$24.67M$111.36M$50.46M-$31.81M$24.23M-$9.72M-$5.52M
    Cash from Investing-$90.74M-$56.95M-$296.06M-$186.88M$33.17M-$85.74M-$23.48M$72.88M-$277.22M
    Cash from Financing$117.18M$24.21M$314.44M$51.93M$16.88M$4.11M$8.37M-$43.37M$277.35M
    SummaryCapital Expenditure-$2.99M-$19.54M-$27.41M-$14.18M-$34.10M-$26.80M-$19.23M-$19.95M-$21.09M
    Free Cash Flow-$11.30M$22.36M-$2.74M$97.18M$16.37M-$58.61M$4.99M-$29.67M-$26.62M
    FCF Margin-6.1%6.2%-0.5%13.8%2.0%-7.8%0.5%-2.9%-2.6%

    Ratios